大庆华科(000985) - 2014 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2014 was ¥339,228,880.24, representing an increase of 80.5% compared to ¥187,933,867.28 in the same period last year[5] - The net profit attributable to shareholders was ¥11,287,548.72, a significant increase of 249.63% from a loss of ¥7,543,555.48 in the previous year[5] - The net cash flow from operating activities reached ¥52,005,122.78, marking a 296.87% increase from a negative cash flow of ¥26,415,440.29 in the prior year[5] - The company expects a cumulative net profit of approximately ¥14 million for the first half of 2014, indicating a growth of 6896.06% compared to the previous year[13] - Basic earnings per share are projected to be ¥0.108, reflecting a growth of 5300% compared to ¥0.002 in the same period last year[13] Assets and Liabilities - The total assets at the end of the reporting period were ¥660,380,261.23, which is a 7.52% increase from ¥614,176,625.25 at the end of the previous year[5] - The company did not incur any borrowings during the reporting period, contrasting with ¥20,000,000.00 received from borrowings in the previous year[12] Sales and Revenue - The company reported a significant increase in sales revenue, with cash received from sales reaching ¥395,570,509.19, up 76.06% from ¥224,684,521.03[12] Shareholding Structure - The major shareholders include China Petroleum Daqing Petrochemical General Factory with a 39.34% stake and China Petroleum Linyuan Refinery with a 15.69% stake[8] Operating Costs - The company has reported a significant increase in operating costs, which rose by 70.20% to ¥295,453,467.62, primarily due to increased sales volume of chemical products[12]